Literature DB >> 11056083

Immune regulation by CD40-CD40-l interactions - 2; Y2K update.

C van Kooten1.   

Abstract

CD40 is a cell surface receptor, which belongs to the TNF-R family, and which was first identified and functionally characterized on B lymphocytes. However, in recent years it has become clear that CD40 is expressed much broader, including expression on monocytes, dendritic cells, endothelial cells and epithelial cells. Therefore it is now thought that CD40 plays a more general role in immune regulation. The present paper reviews recent developments in this field of research, with main emphasis on CD40 signal transduction and on in vivo functions of CD40/CD40-L interactions.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11056083     DOI： 10.2741/kooten

Source DB:  PubMed          Journal:  Front Biosci        ISSN： 1093-4715


  15 in total

1.  TRAF3 Acts as a Checkpoint of B Cell Receptor Signaling to Control Antibody Class Switch Recombination and Anergy.

Authors:  Zhangguo Chen; Alexandra Krinsky; Rachel A Woolaver; Xiaoguang Wang; Samantha M Y Chen; Vince Popolizio; Ping Xie; Jing H Wang
Journal:  J Immunol       Date:  2020-06-26       Impact factor: 5.422

2.  CD40 is expressed and functional on neuronal cells.

Authors:  Jun Tan; Terrence Town; Takashi Mori; Demian Obregon; Yajuan Wu; Anthony DelleDonne; Amyn Rojiani; Fiona Crawford; Richard A Flavell; Mike Mullan
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

3.  Differential induction of nuclear factor-kappaB and activator protein-1 activity after CD40 ligation is associated with primary human hepatocyte apoptosis or intrahepatic endothelial cell proliferation.

Authors:  Jalal Ahmed-Choudhury; Clare L Russell; Satinder Randhawa; Lawrence S Young; David H Adams; Simon C Afford; Jalal Ahmed Choudhury
Journal:  Mol Biol Cell       Date:  2003-04       Impact factor: 4.138

4.  CD40 and tumour necrosis factor-α co-operate to up-regulate inducuble nitric oxide synthase expression in macrophages.

Authors:  Jose-Andres C Portillo; Luis Muniz Feliciano; Genevieve Okenka; Frederick Heinzel; M Cecilia Subauste; Carlos S Subauste
Journal:  Immunology       Date:  2012-02       Impact factor: 7.397

5.  Polypyrimidine tract-binding protein is critical for the turnover and subcellular distribution of CD40 ligand mRNA in CD4+ T cells.

Authors:  Rodrigo Matus-Nicodemos; Stefano Vavassori; Moraima Castro-Faix; Anibal Valentin-Acevedo; Karnail Singh; Valentina Marcelli; Lori R Covey
Journal:  J Immunol       Date:  2011-01-17       Impact factor: 5.422

6.  Inducible CD40 expression mediates NFkappaB activation and cytokine secretion in human colonic fibroblasts.

Authors:  C M Gelbmann; S N Leeb; D Vogl; M Maendel; H Herfarth; J Schölmerich; W Falk; G Rogler
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

7.  In vivo post-transcriptional regulation of CD154 in mouse CD4+ T cells.

Authors:  Stefano Vavassori; Yufang Shi; Chiann-Chyi Chen; Yacov Ron; Lori R Covey
Journal:  Eur J Immunol       Date:  2009-08       Impact factor: 5.532

8.  Variants of the CD40 ligand gene are not associated with increased susceptibility to tuberculosis in West Africa.

Authors:  Sarah J Campbell; Pardis Sabeti; Katherine Fielding; Jackson Sillah; Boubacar Bah; Per Gustafson; Kebba Manneh; Ida Lisse; Giorgio Sirugo; Richard Bellamy; Steve Bennett; Peter Aaby; Keith P W J McAdam; Oumou Bah-Sow; Christian Lienhardt; Adrian V S Hill
Journal:  Immunogenetics       Date:  2003-08-29       Impact factor: 2.846

9.  LMP1, a viral relative of the TNF receptor family, signals principally from intracellular compartments.

Authors:  Ngan Lam; Bill Sugden
Journal:  EMBO J       Date:  2003-06-16       Impact factor: 11.598

10.  A Posttranscriptional Pathway of CD40 Ligand mRNA Stability Is Required for the Development of an Optimal Humoral Immune Response.

Authors:  Bitha Narayanan; Diego Prado de Maio; James La Porta; Yekaterina Voskoboynik; Usha Ganapathi; Ping Xie; Lori R Covey
Journal:  J Immunol       Date:  2021-05-24       Impact factor: 5.426
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.